Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection

被引:55
|
作者
Feuth, Thijs [1 ]
Arends, Joop E. [1 ]
Fransen, Justin H. [1 ,2 ]
Nanlohy, Nening M. [2 ]
van Erpecum, Karel J. [3 ]
Siersema, Peter D. [3 ]
Hoepelman, Andy I. M. [1 ]
van Baarle, Debbie [1 ,2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 03期
关键词
HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CHRONIC VIRAL-INFECTION; TRANSCRIPTION FACTOR; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; EXPRESSION; RESPONSES;
D O I
10.1371/journal.pone.0059302
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives: To investigate whether T-cell activation and exhaustion is linked to HCV- and HIV disease parameters in HIV/HCV infected individuals, we studied T-cell characteristics in HIV/HCV coinfected patients and controls. Methods: 14 HIV/HCV coinfected, 19 HCV monoinfected, 10 HIV monoinfected patients and 15 healthy controls were included in this cross-sectional study. Differences in expression of activation and exhaustion markers (HLA-DR, CD38, PD-1, Tim-3 and Fas) and phenotypic markers on CD4(+) and CD8(+) T-cells were analysed by flow cytometry and were related to HCV disease parameters (HCV-viremia, ALT and liver fibrosis). Results: Frequencies of activated CD4(+) and CD8(+) T-cells were higher in HIV/HCV-coinfected compared to healthy controls and HCV or HIV mono-infected individuals. Coinfected patients also showed high expression of the exhaustion marker PD-1 and death receptor Fas. In contrast, the exhaustion marker Tim-3 was only elevated in HIV-monoinfected patients. T-cell activation and exhaustion were correlated with HCV-RNA, suggesting that viral antigen influences T-cell activation and exhaustion. Interestingly, increased percentages of effector CD8(+) T-cells were found in patients with severe (F3-F4) liver fibrosis compared to those with no to minimal fibrosis (F0-F2). Conclusions: HIV/HCV coinfected patients display a high level of T-cell activation and exhaustion in the peripheral blood. Our data suggest that T-cell activation and exhaustion are influenced by the level of HCV viremia. Furthermore, high percentages of cytotoxic/effector CD8(+) T-cells are associated with liver fibrosis in both HCV monoinfected and HIV/HCV coinfected patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] IMMUNOLOGICAL ASPECTS OF HCV/HIV COINFECTION
    Yuschuk, N. D.
    Shestakova, I. V.
    Balmasova, I. P.
    Vysheslavtseva, M. V.
    Shmeleva, E. V.
    TERAPEVTICHESKII ARKHIV, 2011, 83 (11) : 9 - 14
  • [22] Pathogenesis of HIV-HCV coinfection
    Kim A.Y.
    Lauer G.M.
    Current Infectious Disease Reports, 2007, 9 (4) : 331 - 337
  • [23] Advances in the management of HIV/HCV coinfection
    Mattias Mandorfer
    Philipp Schwabl
    Sebastian Steiner
    Thomas Reiberger
    Markus Peck-Radosavljevic
    Hepatology International, 2016, 10 : 424 - 435
  • [24] HIV and HCV coinfection: What correlation?
    Abrescia, N
    Boccia, L
    DiNicuolo, G
    Esposito, C
    Coppola, C
    Morelli, F
    Busto, A
    Perrella, O
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1997, 10 (02) : 165 - 166
  • [25] HCV and HIV coinfection: Impediments for therapy
    Garcia, MA
    Guda, NM
    Shughoury, AB
    Nadeem, I
    Affi, A
    GASTROENTEROLOGY, 2004, 126 (04) : A722 - A722
  • [26] HIV/HCV Coinfection: Case Report
    Karaosmanoglu, Hayat Kumbasar
    Aydin, Ozlem Altuntas
    Ince, Emine Rahsan
    Nazlican, Ozcan
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2013, 19 (02): : 89 - 91
  • [27] HIV/HCV coinfection: Management update
    Alvarez, D
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2004, 96 (02) : 25 - 26
  • [28] Advances in the management of HIV/HCV coinfection
    Mandorfer, Mattias
    Schwabl, Philipp
    Steiner, Sebastian
    Reiberger, Thomas
    Peck-Radosavljevic, Markus
    HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 424 - 435
  • [29] Role of endogenous interferon in hepatitis C virus (HCV) infection and in coinfection by HIV and HCV
    Cribier, B
    Schmitt, C
    Rey, D
    Lang, JM
    Kirn, A
    StollKeller, F
    RESEARCH IN VIROLOGY, 1996, 147 (05): : 263 - 266
  • [30] Challenges for HCV vaccine development in HIV-HCV coinfection
    Lambotin, Melanie
    Barth, Heidi
    Moog, Christiane
    Habersetzer, Francois
    Baumert, Thomas F.
    Stoll-Keller, Francoise
    Fafi-Kremer, Samira
    EXPERT REVIEW OF VACCINES, 2012, 11 (07) : 791 - 804